The Center for American Progress supports a proposal from the CMS that would benefit patients by testing different ways to pay for expensive drugs.
Issue Brief Cutting corners by pushing the FDA to approve more drugs on the basis of more limited data will put patients at risk.
Issue Brief Experiences from past mergers show that divestitures most likely will not be a successful remedy in the proposed Aetna-Humana merger.
Issue Brief A proposed merger between Aetna and Humana, two of the country’s largest health insurance companies, likely would increase costs for consumers and taxpayers.
Report Creating a new Medicaid benefit for evidence-based home visiting services would simplify funding and allow states and communities to scale services, improve outcomes for families, and produce significant savings for states and the federal government.
Neera Tanden and Maura Calsyn write about how to foster drug research while discouraging profiteering.
Report Sustainable drug pricing requires paying for drugs based on their benefits to patients.
The current draft of the TPP will raise drug prices and hinder access to critical medications.
Report Cost shifting from employers to employees—not the Affordable Care Act—is the reason why employees continue to experience growing health care costs. Employees should be aware of these cost-shifting efforts and share in health care cost savings.
Issue Brief Targeted reforms will help more Americans afford the long-term care they are likely to need in the coming decades.
Maura Calsyn, Director of Health Policy, testifies before the U.S. House Subcommittee on Health, Employment, Labor, and Pensions.
Issue Brief A move by small businesses toward self-insurance schemes could undermine the reforms of the Affordable Care Act and offer fewer protections for workers.